
Immunairevenue & acquisition
Pharma and Biotech SoftwareNew YorkFounded 2019
Immunai was acquired.
Immunai is a Pharma and Biotech Software company based in New York, founded in 2019.
Immunai revenue
Immunai has not published its revenue. Growjo puts it at about $39.1M a year (December 2023).
| As of | Revenue | Source |
|---|---|---|
| Dec 2023 | $39.1MEST | Growjo estimate |
Who owns Immunai
Another company owns Immunai. The date and price of the deal are not on record.
Immunai CEO, founders & employees
Noam Solomon founded Immunai in 2019 and led it as CEO. Immunai had 194 employees (December 2023, Growjo estimate).
- Noam SolomonFounder & CEO
All 2 headcount readings, with sources
| As of | Employees | Source |
|---|---|---|
| Dec 2023 | 194EST | Growjo estimate |
| Dec 2022 | 153EST | Growjo estimate |
Immunai FAQ
What was Immunai's revenue?
Growjo estimates Immunai's revenue at about $39.1M a year (December 2023). The company hasn't published its own figure.
How many employees does Immunai have?
Growjo estimates Immunai's headcount at about 194 (December 2023).
Who founded Immunai?
Noam Solomon founded Immunai in 2019.
Browse Pharma and Biotech Software
How this page is sourced
3 estimates. Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.
Updated Oct 30, 2026Data disclaimerReport a correctionClaim this profileRun Immunai? Join the podcast